Zhu X J, Niimi Y, Bystryn J C
Department of Dermatology, New York University School of Medicine, NY.
J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):876-80. doi: 10.1016/0190-9622(90)70308-5.
The skin antigens defined by basement membrane zone antibodies in 38 patients with bullous pemphigoid were analyzed by Western immunoblot. Thirty-four patients (89%) had antibodies to a major bullous pemphigoid antigen with a molecular weight of approximately 230 kD. Twelve patients (32%) had antibodies to a minor bullous pemphigoid antigen with a molecular weight of approximately 160 kD; this included four patients who did not have antibodies to the 230 kD antigen. Depending on the epidermal extract used, a variable number of patients (up to 75%) also had antibodies to minor bullous pemphigoid antigens with molecular weights of approximately 180 and 200 kD. The results of this study confirm that bullous pemphigoid antigens are heterogeneous at the molecular level. Approximately 10% of patients have antibodies directed solely to a minor bullous pemphigoid antigen.
采用蛋白质免疫印迹法对38例大疱性类天疱疮患者中由基底膜带抗体所定义的皮肤抗原进行了分析。34例患者(89%)具有针对一种分子量约为230kD的主要大疱性类天疱疮抗原的抗体。12例患者(32%)具有针对一种分子量约为160kD的次要大疱性类天疱疮抗原的抗体;这其中包括4例不具有针对230kD抗原的抗体的患者。根据所使用的表皮提取物不同,可变数量的患者(高达75%)还具有针对分子量约为180kD和200kD的次要大疱性类天疱疮抗原的抗体。本研究结果证实,大疱性类天疱疮抗原在分子水平上具有异质性。约10%的患者仅具有针对一种次要大疱性类天疱疮抗原的抗体。